Advaxis Inc. appointed Molly Henderson executive vice president and CFO, effective June 6.
Before Advaxis, Henderson worked at Cedar Cliff LLC, where she served as a financial and business consultant to entrepreneurial companies.
Princeton, N.J.-based Advaxis is a clinical stage biotechnology company, which focuses on the discovery, development and commercialization of Listeria monocytogenes technology-based immunotherapies in the U.S.
